A randomized, double‐blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids-Reference-Cited by-同舟云学术

A randomized, double‐blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids

Published:2020-03-04 Issue:5 Volume:24 Page:983-991
ISSN:1090-3801
Container-title:European Journal of Pain
language:en
Short-container-title:Eur J Pain

Author:

Currow David C.¹²,Clark Katherine³,Louw Sandra⁴,Fazekas Belinda¹⁵,Greene Aine⁵,Sanderson Christine R.¹⁶

Affiliation:

1. IMPACCT Faculty of Health University of Technology Sydney Ultimo NSW Australia

2. Australian National Cancer Symptom Trials Group University of Technology Sydney Ultimo NSW Australia

3. University of Sydney Northern Clinical School Royal North Shore Hospital St Leonard's NSW Australia

4. McCloud Consulting Group Belrose NSW Australia

5. Southern Adelaide Palliative Services Daw Park SA Australia

6. Calvary Health Care Kogarah Kogarah NSW Australia

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.1548

Reference23 articles.

1. A survey of Canadian cancer patients’ perspectives on the characteristics and treatment of breakthrough pain

2. Cancer Council Australia.Cancer pain management in adults. (2016) Evidence‐based clinical practice guidelines adapted for use in Australia.https://wiki.cancer.org.au/australia/Guidelines:Cancer_pain_management/Summary_of_recommendations#top.

3. Guidelines for the Management of Breakthrough Pain in Patients With Cancer

4. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey

5. An international survey of cancer pain characteristics and syndromes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medikamentöse Schmerztherapie bei Patienten mit Tumorerkrankungen;Die Urologie;2024-04-10

2. Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital;Current Oncology;2024-03-05

3. Once again... breakthrough cancer pain: an updated overview;Journal of Anesthesia, Analgesia and Critical Care;2023-07-21

4. Medikamentöse Schmerztherapie bei Patienten mit Tumorerkrankungen;Die Onkologie;2023-07-06

5. An overview of the current drug treatment strategies for moderate to severe, chronic malignant tumor-related pain;Expert Opinion on Pharmacotherapy;2023-04-09